About
Anebulo Pharmaceuticals develops Selonabant, a drug candidate designed to reverse acute cannabis-induced toxicities such as central nervous system and respiratory depression, with a focus on unintentional cannabis exposure in children.
Explore Anebulo Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.